SOM Stock Overview
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SomnoMed Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.20 |
| 52 Week High | AU$1.04 |
| 52 Week Low | AU$0.20 |
| Beta | 1 |
| 1 Month Change | -44.44% |
| 3 Month Change | -59.18% |
| 1 Year Change | -79.70% |
| 3 Year Change | -89.64% |
| 5 Year Change | -88.57% |
| Change since IPO | -92.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| SOM | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -2.4% | 2.1% | 0.9% |
| 1Y | -79.7% | 13.8% | 5.6% |
Return vs Industry: SOM underperformed the Australian Medical Equipment industry which returned 13.8% over the past year.
Return vs Market: SOM underperformed the Australian Market which returned 5.6% over the past year.
Price Volatility
| SOM volatility | |
|---|---|
| SOM Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: SOM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SOM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Neil Verdal-Austin | somnomed.com/au/ |
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively.
SomnoMed Limited Fundamentals Summary
| SOM fundamental statistics | |
|---|---|
| Market cap | AU$28.58m |
| Earnings (TTM) | -AU$10.51m |
| Revenue (TTM) | AU$88.77m |
0.3x
P/S Ratio-2.7x
P/E RatioIs SOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOM income statement (TTM) | |
|---|---|
| Revenue | AU$88.77m |
| Cost of Revenue | AU$33.95m |
| Gross Profit | AU$54.82m |
| Other Expenses | AU$65.33m |
| Earnings | -AU$10.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.077 |
| Gross Margin | 61.76% |
| Net Profit Margin | -11.84% |
| Debt/Equity Ratio | 40.0% |
How did SOM perform over the long term?
See historical performance and comparison